EcoDrugPlus

Protein Kinase C Iota

Ensembl ID : ENSCMIG00000010060
Gene Symbol: PRKCI
4 Cross references
270 Possible Orthologues:

Protein Kinase C Theta

Ensembl ID : ENSCMIG00000012526
Gene Symbol: PRKCQ
4 Cross references
205 Possible Orthologues:

Protein Kinase C Zeta

Ensembl ID : ENSCMIG00000004370
Gene Symbol: PRKCZ
4 Cross references
205 Possible Orthologues:

Protein Kinase D1

Ensembl ID : ENSCMIG00000004110
Gene Symbol: PRKD1
3 Cross references
213 Possible Orthologues:

Protein Kinase D3

Ensembl ID : ENSCMIG00000019663
Gene Symbol: PRKD3
4 Cross references
277 Possible Orthologues:

Protein Kinase, Dna-Activated, Catalytic Subunit

Ensembl ID : ENSCMIG00000005962
Gene Symbol: PRKDC
3 Cross references
187 Possible Orthologues:

Protein Phosphatase 3 Catalytic Subunit Alpha

Ensembl ID : ENSCMIG00000014612
Gene Symbol: PPP3CA
3 Cross references
233 Possible Orthologues:

Protein Tyrosine Kinase 2

Ensembl ID : ENSCMIG00000016291
Gene Symbol: PTK2
4 Cross references
246 Possible Orthologues:

Protein Tyrosine Kinase 6

Ensembl ID : ENSCMIG00000016185
Gene Symbol: PTK6
3 Cross references
174 Possible Orthologues:

Protein Tyrosine Phosphatase Non-Receptor Type 11

Ensembl ID : ENSCMIG00000015984
Gene Symbol: PTPN11
4 Cross references
253 Possible Orthologues:

Protein Tyrosine Phosphatase Receptor Type B

Ensembl ID : ENSCMIG00000019637
Gene Symbol: PTPRB
3 Cross references
268 Possible Orthologues:

Proteinase-Activated Receptor 1-Like

Ensembl ID : ENSCMIG00000001298
Gene Symbol: LOC103186383
3 Cross references
329 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).